Clinical Trial: THE EFFECTIVENESS OF FOREST THERAPY ON PSYCHOTIC PATIENTS: FOCUSING ON CHANGES IN INFLAMMATORY PATHWAYS AND THE PSYCHOTIC CONDITION OF PATIENTS

U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07436481) titled 'THE EFFECTIVENESS OF FOREST THERAPY ON PSYCHOTIC PATIENTS: FOCUSING ON CHANGES IN INFLAMMATORY PATHWAYS AND THE PSYCHOTIC CONDITION OF PATIENTS' on Feb. 21.

Brief Summary: General Formulation Are there any changes in the inflammatory pathway and psychotic conditions in patients given Forest Therapy compared to conventional psychotic disorder therapy? Specific Are there any differences in the levels of inflammatory factors such as CRP, IL-6, and BDNF in patients given Forest Therapy compared to conventional psychotic disorder therapy? Are there differences in the psychotic conditions of patients, as assessed by PANSS, MADRSS, DASS-21...